Correvio Pharma Corp.: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2019)
- $32.6M
- Net Income/Loss (FY2019)
- -$35.2M
- Total Assets (FY2019)
- $58.9M
- Total Equity (FY2019)
- -$834.0K
- Cash Flows from Operating Activities (FY2019)
- -$27.1M
Source: Correvio Pharma Corp. 20-F filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
